As of November 2024, AstraZeneca Pharma India has a market cap of $1.99B. This makes AstraZeneca Pharma India the world's 5213th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.65B | -0.29% |
2023 | $1.65B | 67.62% |
2022 | $984.92M | 6.42% |
2021 | $925.50M | -32.93% |
2020 | $1.38B | 76.53% |
2019 | $781.63M | 80.26% |
2018 | $433.62M | 24.37% |
2017 | $348.65M | 26.00% |
2016 | $276.70M | -25.77% |
2015 | $372.79M | 45.04% |
2014 | $257.02M | 2.91% |
2013 | $249.76M | -36.37% |
2012 | $392.53M | 7.53% |
2011 | $365.03M | -7.15% |
2010 | $393.13M | 39.75% |
2009 | $281.30M | 91.32% |
2008 | $147.03M | -24.95% |
2007 | $195.91M | 9.73% |
2006 | $178.54M | 17.56% |
2005 | $151.88M | 48.32% |
2004 | $102.40M | 74.30% |
2003 | $58.75M | 175.56% |
2002 | $21.32M | - |